Related Experiment Video
Updated: Aug 16, 2025
06:21
Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
1.6K
Recurrent Hypoglycaemia In An Older Individual With Covid-19
Tayyabah Usman1, Shahnoor Ahmed1, Saniya Sabzwari1
1Aga Khan University Hospital, Karachi, Pakistan.
Journal of Ayub Medical College, Abbottabad : JAMC
|December 23, 2022
Summary
Older adults with COVID-19 may present with atypical symptoms like recurrent hypoglycemia. This case highlights the importance of monitoring blood sugar in elderly patients during the pandemic.
Area of Science:
- Gerontology
- Infectious Diseases
- Endocrinology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic disproportionately affects older adults.
- Pre-existing conditions like diabetes mellitus increase severity and mortality risk in elderly COVID-19 patients.
- Altered immune responses in older individuals contribute to higher morbidity.
Observation:
- Older patients may exhibit atypical COVID-19 symptoms, including confusion and absence of fever.
- Poor glycemic control is an indicator of COVID-19 severity.
- Elderly individuals with diabetes are susceptible to hypoglycemia, increasing risks of adverse events.
Findings:
- Presents a case of an elderly male with COVID-19 primarily manifesting as recurrent hypoglycemia and weakness.
- Highlights hypoglycemia as a key presenting symptom in older adults with SARS-CoV-2 infection.
- Underscores the link between glycemic dysregulation and COVID-19 severity in the elderly.
Implications:
- Emphasizes the need for vigilant glycemic monitoring in older diabetic patients with COVID-19.
- Suggests considering atypical presentations, such as hypoglycemia, in the diagnosis of COVID-19 in the elderly.
- Addresses the broader social impact of COVID-19 on vulnerable older populations and their support systems.
Related Concept Videos
01:15Hypoglycemia and Glucagon
311
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
311
01:19Overview of Carbohydrate Metabolism
1.4K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.4K
01:22Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
645
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
645
01:22Diabetes Mellitus: Overview and Type I Subtype
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
01:06Oral Hypoglycemic Agents: Glinides
211
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
211